Skip to Content

Popular

Having trouble identifying your medications? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Featured Tool

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Featured Tool

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Featured Tool

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Medical

Health Tip: Keep Kids Safe Outdoors

-- A few rules from parents or guardians can help keep children safe while they get exercise and enjoy the great outdoors. The extension.org website suggests: Never allow children to play outside without supervision. Explain to children that they should never play near a street or driveway. Teach children to ask an adult for help for any object that...

Posted today in Medical

Health Tip: Should I Bandage a Wound?

-- Proper wound care can promote healing and ward off infection. The American Academy of Family Physicians advises: An unbandaged wound typically stays more dry and heals more quickly. Wounds that may become dirty or may be irritated by clothing should be bandaged. Use bandages with an adhesive strip and sterile gauze. Change the bandage daily. Use...

Posted yesterday in New Drug Approvals

FDA Approves Orkambi (lumacaftor/ivacaftor) for Cystic Fibrosis

The U.S. Food and Drug Administration today approved the first drug for cystic fibrosis directed at treating the cause of the disease in people who have two copies of a specific mutation. Orkambi (lumacaftor 200 mg/ivacaftor 125 mg) is now approved to treat cystic fibrosis (CF) in patients 12 years and older, who have the F508del mutation, which...

Posted 2 days ago in New Drug Approvals

Spriaso Announces FDA Approval of Long Acting Tuxarin ER (codeine and chlorpheniramine)

Spriaso LLC today announced FDA approval of a New Drug Application (NDA) for Tuxarin ER, a unique high strength long acting Rx cough/cold combination product containing codeine and chlorpheniramine. Tuxarin ER, co-developed with Nexgen Pharma, will be the first product to offer long lasting cough suppression with a safer opiate that is less prone to...

Posted 3 days ago in FDA Alerts

Codeine Cough-and-Cold Medicines in Children: Drug Safety Communication - FDA Evaluating Potential Risk of Serious Side Effects

ISSUE: FDA is investigating the safety of using codeine-containing medicines to treat coughs and colds in children under 18 years because of the potential for serious side effects, including slowed or difficult breathing. Children, especially those who already have breathing problems, may be more susceptible to these serious side effects. In 2013,...

Posted today in Medical

Plane Passengers' Near-Death Experience Gives Clues to Trauma's Effect on Brain

A study involving people who thought they were about to die in a plane crash reveals new clues to the long-term impact that traumatic events have on the brain. In August of 2001, passengers on Air Transat flight 236 were on an overnight flight from Toronto to Lisbon, Portugal, when their plane ran out of fuel over the Atlantic Ocean. Many on the harrowing...

Posted today in Medical

Many New Teen Drivers 'Crash' in Simulated Driving Task

Around four in 10 newly licensed teen drivers "crashed" in a simulated driving test, suggesting that many adolescents lack the skills they need to stay safe on the road, according to a new study. The simulated driving assessment (SDA) included a 35-minute "drive" replicating 22 variations of the most common scenarios that often cause teens to crash. "During...

Posted today in Medical

Noise From Fireworks Threatens Young Ears

The Fourth of July weekend is a time for celebrations and beautiful fireworks displays. But, parents do need to take steps to protect their children's ears from loud fireworks, a hearing expert cautions. "Fireworks can be harmful to a child's ears," Dr. Laura Swibel Rosenthal, a pediatric ear, nose and throat doctor at Loyola University Health System...

Posted today in Medical

Childhood Trauma Tied to Migraine Risk as Adult

Experiencing a traumatic event during childhood may raise the risk for migraines as an adult, new Canadian research suggests. "We found the more types of violence the individual had been exposed to during their childhood, the greater the odds of migraine," study author Sarah Brennenstuhl, from the University of Toronto, said in a university news release. "For...

Posted 2 days ago in Pharma Industry News

FDA Takes Action Against Unapproved Prescription Ear Drop Products

The U.S. Food and Drug Administration today announced its intention to take enforcement action against companies that manufacture and/or distribute certain unapproved prescription ear drop products (known as otic products) labeled to relieve ear pain, infection, and inflammation. The unapproved prescription ear drops contain active ingredients such...

Read more news...

Recently added consumer and prescribing information: Orkambi, Viberzi, Stiolto Respimat, Kybella, Corlanor, Cresemba, Zarxio, Farydak, Lenvima, Ibrance

Posted in Blog

Drug Shortages: Has the FDA Response Made an Impact?

Rationing of much needed medications for patients is a scary thought for me as a healthcare professional. I can understand when an orphan drug may go in short supply for a rare disease, but when commonly used medications like antibiotics and intravenous fluids become scarce, I wonder what the forces are that cause this to […]

Posted in Blog

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in injecting the […]

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

See more blog posts or follow us on twitter.

(web4)